Comparison of Paricalcitol (I.V) and Alfacalcidol (I.V) in Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients
ABSTRACT Objective of study: To Compare the efficacy of Alfacalcidol (I.V) and Paricalcitol (I.V) for the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis patients. Materials and Methods: An open-label randomized clinical trial carried out to compare the efficacy of in...
Main Authors: | Mansoor Abbas Qaisar, Zain ul Abideen, Fateh Sher Chattah, Muhammad Nadeem, Zahid Hafeez |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2020-12-01
|
Series: | Journal of Rawalpindi Medical College |
Subjects: | |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/1468 |
Similar Items
-
DIAGNOSIS AND TREATMENT OF PATIENTS WITH SECONDARY HYPERPARATHYROIDISM AND RENAL INSUFFICIENCY. THERAPEUTIC POTENTIAL OF PARICALCITOL
by: Zh. E. Belaya, et al.
Published: (2018-01-01) -
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
by: Josep M. Cruzado, et al.
Published: (2018-01-01) -
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
by: Francisco José Borrego Utiel, et al.
Published: (2015-07-01) -
Intermittent Oral Versus Intravenous Alfacalcidol in Dialysis Patients
by: Mitwalli Ahmed, et al.
Published: (2000-01-01) -
Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
by: Jacek Zawierucha, et al.
Published: (2019-02-01)